Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2173965440;65441;65442 chr2:178584336;178584335;178584334chr2:179449063;179449062;179449061
N2AB2009860517;60518;60519 chr2:178584336;178584335;178584334chr2:179449063;179449062;179449061
N2A1917157736;57737;57738 chr2:178584336;178584335;178584334chr2:179449063;179449062;179449061
N2B1267438245;38246;38247 chr2:178584336;178584335;178584334chr2:179449063;179449062;179449061
Novex-11279938620;38621;38622 chr2:178584336;178584335;178584334chr2:179449063;179449062;179449061
Novex-21286638821;38822;38823 chr2:178584336;178584335;178584334chr2:179449063;179449062;179449061
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: K
  • RefSeq wild type transcript codon: AAA
  • RefSeq wild type template codon: TTT
  • Domain: Fn3-45
  • Domain position: 81
  • Structural Position: 113
  • Q(SASA): 0.7493
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
K/N rs1457832691 0.236 0.324 N 0.34 0.12 0.204665344411 gnomAD-2.1.1 4.06E-06 None None None None I None 0 2.91E-05 None 0 0 None 0 None 0 0 0
K/N rs1457832691 0.236 0.324 N 0.34 0.12 0.204665344411 gnomAD-4.0.0 1.60857E-06 None None None None I None 0 2.29495E-05 None 0 0 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
K/A 0.5199 ambiguous 0.4357 ambiguous 0.049 Stabilizing 0.207 N 0.456 neutral None None None None I
K/C 0.8624 likely_pathogenic 0.7816 pathogenic -0.235 Destabilizing 0.981 D 0.439 neutral None None None None I
K/D 0.8045 likely_pathogenic 0.7439 pathogenic -0.018 Destabilizing 0.388 N 0.464 neutral None None None None I
K/E 0.3315 likely_benign 0.282 benign -0.015 Destabilizing 0.09 N 0.367 neutral N 0.448234857 None None I
K/F 0.9099 likely_pathogenic 0.8661 pathogenic -0.209 Destabilizing 0.69 D 0.495 neutral None None None None I
K/G 0.7173 likely_pathogenic 0.6339 pathogenic -0.129 Destabilizing 0.388 N 0.537 neutral None None None None I
K/H 0.4969 ambiguous 0.4128 ambiguous -0.361 Destabilizing 0.818 D 0.409 neutral None None None None I
K/I 0.5236 ambiguous 0.4475 ambiguous 0.437 Stabilizing 0.193 N 0.529 neutral N 0.440367522 None None I
K/L 0.4411 ambiguous 0.3557 ambiguous 0.437 Stabilizing 0.002 N 0.253 neutral None None None None I
K/M 0.3563 ambiguous 0.3015 benign 0.153 Stabilizing 0.054 N 0.401 neutral None None None None I
K/N 0.6697 likely_pathogenic 0.6059 pathogenic 0.194 Stabilizing 0.324 N 0.34 neutral N 0.491409631 None None I
K/P 0.8381 likely_pathogenic 0.7726 pathogenic 0.335 Stabilizing 0.818 D 0.442 neutral None None None None I
K/Q 0.2066 likely_benign 0.1743 benign 0.047 Stabilizing 0.018 N 0.294 neutral N 0.436999143 None None I
K/R 0.0818 likely_benign 0.0752 benign -0.029 Destabilizing 0.001 N 0.125 neutral N 0.429630453 None None I
K/S 0.6589 likely_pathogenic 0.5796 pathogenic -0.24 Destabilizing 0.388 N 0.317 neutral None None None None I
K/T 0.3572 ambiguous 0.3031 benign -0.096 Destabilizing 0.324 N 0.493 neutral N 0.453448675 None None I
K/V 0.4743 ambiguous 0.3958 ambiguous 0.335 Stabilizing 0.241 N 0.519 neutral None None None None I
K/W 0.9012 likely_pathogenic 0.8513 pathogenic -0.269 Destabilizing 0.981 D 0.465 neutral None None None None I
K/Y 0.7965 likely_pathogenic 0.7193 pathogenic 0.093 Stabilizing 0.818 D 0.499 neutral None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.